Autolus Therapeutics's total assets for Q2 2025 were $720.98M, a decrease of -3.40% from the previous quarter. AUTL total liabilities were $374.52M for the fiscal quarter, a -0.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.